Form D · Other
HbA1c, LP
Los Angeles, CA · CIK 0002094213
Offering snapshot reported Nov 5, 2025 · SEC filing
- Reported sold
- $4.8M Offering amount: $11.5M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 20, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 5, 2025 | Initial | $4,800,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-563066
Source: Form D, filed Nov 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bryan Johnson | Executive |
| Jason Johnson | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
5042 Wilshire Blvd. #26878
Los Angeles, CA, 90036
Los Angeles, CA, 90036